# Qi Zhou

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/qi-zhou/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,292 |
| Field | Cervical Cancer and HPV Research |
| h-index | 35 |
| i10-index | 79 |
| Last Known Institution | Beijing Institute of Technology |
| OpenAlex ID | https://openalex.org/A5100650222 |
| ORCID iD | 0000-0001-5673-4263 |
| Works | 175 |

## Researcher papers

- [Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial](https://scholariq.org/papers/durvalumab-plus-carboplatin-paclitaxel-followed-by-maintenance-durvalumab-with/)
- [Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis](https://scholariq.org/papers/systemic-immune-inflammation-index-predicts-prognosis-of-patients-with/)
- [Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System](https://scholariq.org/papers/materializing-the-potential-of-small-interfering-rna-via-a-tumor-targeting/)
- [The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells](https://scholariq.org/papers/the-m6a-eraser-fto-facilitates-proliferation-and-migration-of-human-cervical/)
- [Tumor-Targeting Nanoimmunoliposome Complex for Short Interfering RNA Delivery](https://scholariq.org/papers/tumor-targeting-nanoimmunoliposome-complex-for-short-interfering-rna-delivery/)
- [Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China](https://scholariq.org/papers/effectiveness-of-high-risk-human-papillomavirus-testing-for-cervical-cancer/)
- [A multi-center survey of age of sexual debut and sexual behavior in Chinese women: Suggestions for optimal age of human papillomavirus vaccination in China](https://scholariq.org/papers/a-multi-center-survey-of-age-of-sexual-debut-and-sexual-behavior-in-chinese/)
- [Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18](https://scholariq.org/papers/human-papillomavirus-type-distribution-in-cervical-cancer-in-china-the/)
- [Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer](https://scholariq.org/papers/efficacy-of-adjuvant-immunotherapy-with-cytokine-induced-killer-cells-in/)
- [PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer](https://scholariq.org/papers/pd-l1-expression-promotes-epithelial-to-mesenchymal-transition-in-human/)
- [Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort](https://scholariq.org/papers/olaparib-maintenance-therapy-in-patients-with-newly-diagnosed-advanced-ovarian/)

## Researcher topics

- [Cervical Cancer and HPV Research](https://scholariq.org/topics/cervical-cancer-and-hpv-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Global Cancer Incidence and Screening](https://scholariq.org/topics/global-cancer-incidence-and-screening/)
- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

## Researcher university

- [Beijing Institute of Technology](https://scholariq.org/institutions/beijing-institute-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.